BiotechTube
Home/Breye Therapeutics/Kaare G Rasmussen
KG

Kaare G Rasmussen

Head of CMC

Breye Therapeutics

Therapeutic Areas

OphthalmologyRetinal Diseases

Breye Therapeutics Pipeline

DrugIndicationPhase
DanegaptideDiabetic RetinopathyPhase 2
Oral P2X7 Receptor AntagonistsDiabetic Retinopathy / Age-related Macular DegenerationPreclinical

Leadership Team at Breye Therapeutics

UM
Ulrik Mouritzen
CEO
PA
Peter Adamson
CSO
TB
Tom Biancardi
Financial Advisor
BE
Benedikte el-Bandak Lind
Head of Clinical Operations
MT
Magali Taiel
CMO Consultant
View full Breye Therapeutics profile